ACUTE ORAL TOLERABILITY AND ANTI-INFLAMMATORY ACTIVITY OF 1,3,4-THIADIAZOLE DERIVATIVES: A SECONDARY ANALYSIS
Keywords:
1,3,4-thiadiazole; anti-inflammatory activity; acute oral toxicity; carrageenan; dose–response; secondary analysis.Abstract
Functionally substituted 1,3,4-thiadiazoles have shown activity in preliminary in vivo inflammation screens, while their acute tolerability has been described in mice. Objective: To synthesise published safety and efficacy observations into a transparent early-stage prioritisation framework. Methods: A descriptive secondary analysis was conducted using two 2024 reports on acute oral dosing and carrageenan-induced edema. Mortality, body-mass observations, dose levels and published percentage edema inhibition were extracted. No new animal work or statistical hypothesis tests were performed. Results: The original report documented 0/5 deaths per studied compound after a single oral dose of 2,000 mg/kg, with transient clinical signs. The same publications reported anti-inflammatory effects at 50 and 100 mg/kg. For the bis(sulfanediyl) diacetohydrazide, edema inhibition at 24 hours was 40.0% at 50 mg/kg versus 30.5% at 100 mg/kg; for the diethyl diacetate, corresponding figures were 34.6% and 23.4%. These descriptive observations are not evidence of a monotonic dose–response. Conclusion: The series merits confirmatory pharmacological investigation, but the mortality-based acute screen does not establish chronic safety or therapeutic index, and efficacy findings need replication using a documented statistical plan.
References
1.Basirova, G. R., Makhmudov, L. U., Usmonov, Sh. T., Tagayalieva, N. A., & Babayev, B. N. (2024). Определение острой токсичности и воспалительной активности производных 1,3,4-тиадиазолов [Determination of acute toxicity and inflammatory activity of 1,3,4-thiadiazole derivatives]. Journal of IQRO, 13(1).
2.Basirova, G. R., Zhaloliddinov, F. Yu., Makhmudov, L. U., & Babayev, B. N. (2024). Synthesis and pharmacological evaluation of new 1,3,4-thiadiazole derivatives. Science and Innovation, 3(11), 139–143. https://doi.org/10.5281/zenodo.14251419
3.OECD. (2002). Test No. 420: Acute Oral Toxicity—Fixed Dose Procedure. OECD Publishing. https://doi.org/10.1787/9789264070943-en
4.Basirova, G. R. (2024). Молекулярный докинг производных 1,3,4 тиадиазола [Molecular docking of 1,3,4-thiadiazole derivatives]. Academic Research in Modern Science, 121–122. https://doi.org/10.5281/zenodo.13968337




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal